AngioDynamics Appoints Eric Honroth as New President and CEO

Key Facts

1AngioDynamics announced the appointment of Eric Honroth as President, CEO, and board member, effective November 2, 2026.

2Honroth will succeed current CEO Jim Clemmer, who is set to depart the board in November.

AngioDynamics announced the appointment of Eric Honroth as President, CEO, and board member, effective November 2, 2026. According to a company statement via Business Wire, Honroth will succeed current CEO Jim Clemmer, who is set to depart the board in November.

ANGO closed at $14.19 on October 7, 2026, with the stock reaching a session high of $14.51 and a low of $14.13. This leadership transition marks a strategic shift for the medical technology firm as it prepares for the executive handover next month.